跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
Approved
STANDARD
ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
Pfizer Europe Ma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 1, 2023
Approval ID
6977c02e8df38fc3
Company
Pfizer Europe Ma Eeig
Type
Standard
Approval Details
Approval Id
6977c02e8df38fc3
Drug Cima Aemps Name
ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
Register Number
1231752001
Holder Company Name
Pfizer Europe Ma Eeig
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/pfizer-europe-ma-eeig
Authorization Date
2023-09-01
Dosage Form
POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE
Dose
60 microgramos/dosis + 60 microgramos/dosis
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Pfizer Europe Ma Eeig
Company Detail Path
/organization/pfizer-europe-ma-eeig
Company Information
Pharmaceutical Company Name
Pfizer Europe MA EEIG
Country Name
United Kingdom
Active Ingredients
VIRUS SINCITIAL RESPIRATORIO, SUBGROUPO A, SUBUNIDAD F PROTEINA 847A ESTABILIZADA EN PREFUSION
0,06 mg
VIRUS SINCITIAL RESPIRATORIO, SUBGROUPO B, SUBUNIDAD F PROTEINA 847B ESTABILIZADA EN PREFUSION
0,06 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 1, 2023
Approval ID
6977c02e8df38fc3
Type
Standard
Back to CIMA-AEMPS Approvals
